Coverage
-
April 08, 2015
A New York federal judge on Wednesday ruled that although Amneal Pharmaceuticals LLC infringed Purdue Pharma LP's patent with its generic version of an abuse-resistant variety of the pain medication OxyContin, Purdue's asserted claims are invalid as obvious and indefinite.
10 other articles on this case.
View all »